image
Healthcare - Medical - Instruments & Supplies - NASDAQ - US
$ 169.72
1.08 %
$ 9.2 B
Market Cap
-30.17
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on Jun, 6, 2025.

The intrinsic value of one MASI stock under the worst case scenario is HIDDEN Compared to the current market price of 170 USD, Masimo Corporation is HIDDEN

This DCF valuation model was last updated on Jun, 6, 2025.

The intrinsic value of one MASI stock under the base case scenario is HIDDEN Compared to the current market price of 170 USD, Masimo Corporation is HIDDEN

This DCF valuation model was last updated on Jun, 6, 2025.

The intrinsic value of one MASI stock under the best case scenario is HIDDEN Compared to the current market price of 170 USD, Masimo Corporation is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart MASI

image
$195.0$195.0$190.0$190.0$185.0$185.0$180.0$180.0$175.0$175.0$170.0$170.0$165.0$165.0$160.0$160.0$155.0$155.0$150.0$150.0$145.0$145.0$140.0$140.015 Dec15 DecJan '25Jan '2515 Jan15 JanFeb '25Feb '2515 Feb15 FebMar '25Mar '2515 Mar15 MarApr '25Apr '2515 Apr15 AprMay '25May '2515 May15 MayJun '25Jun '25
FINANCIALS
2.09 B REVENUE
2.26%
-267 M OPERATING INCOME
-195.38%
-305 M NET INCOME
-374.11%
196 M OPERATING CASH FLOW
108.71%
-51.2 M INVESTING CASH FLOW
36.95%
-126 M FINANCING CASH FLOW
-119.96%
372 M REVENUE
-38.07%
78 M OPERATING INCOME
121.73%
47.2 M NET INCOME
113.50%
31.1 M OPERATING CASH FLOW
-38.42%
10.7 M INVESTING CASH FLOW
164.85%
-47.8 M FINANCING CASH FLOW
-635.38%
Balance Sheet Masimo Corporation
image
Current Assets 1.23 B
Cash & Short-Term Investments 178 M
Receivables 489 M
Other Current Assets 559 M
Non-Current Assets 1.4 B
Long-Term Investments 8.6 M
PP&E 382 M
Other Non-Current Assets 1.01 B
6.76 %18.64 %21.29 %14.53 %38.45 %Total Assets$2.6b
Current Liabilities 618 M
Accounts Payable 253 M
Short-Term Debt 37.3 M
Other Current Liabilities 328 M
Non-Current Liabilities 956 M
Long-Term Debt 787 M
Other Non-Current Liabilities 169 M
16.06 %20.82 %50.03 %10.72 %Total Liabilities$1.6b
EFFICIENCY
Earnings Waterfall Masimo Corporation
image
Revenue 2.09 B
Cost Of Revenue 1.09 B
Gross Profit 1 B
Operating Expenses 1.27 B
Operating Income -267 M
Other Expenses 38.2 M
Net Income -305 M
3b3b2b2b2b2b1b1b500m500m00(500m)(500m)2b(1b)1b(1b)(267m)(38m)(305m)RevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income
RATIOS
47.96% GROSS MARGIN
47.96%
-12.73% OPERATING MARGIN
-12.73%
-14.56% NET MARGIN
-14.56%
-28.99% ROE
-28.99%
-11.61% ROA
-11.61%
-13.02% ROIC
-13.02%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Masimo Corporation
image
400m400m350m350m300m300m250m250m200m200m150m150m100m100m50m50m00(50m)(50m)201720172018201820192019202020202021202120222022202320232024202420252025
Net Income -305 M
Depreciation & Amortization 103 M
Capital Expenditures -20 M
Stock-Based Compensation 41.5 M
Change in Working Capital 0
Others 406 M
Free Cash Flow 176 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets Masimo Corporation
image
Wall Street analysts predict an average 1-year price target for MASI of $182 , with forecasts ranging from a low of $165 to a high of $210 .
MASI Lowest Price Target Wall Street Target
165 USD -2.78%
MASI Average Price Target Wall Street Target
182 USD 7.00%
MASI Highest Price Target Wall Street Target
210 USD 23.73%
Price
Max Price Target
Min Price Target
Average Price Target
220220200200180180160160140140120120100100Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26Jun '26Jun '26
4. DIVIDEND ANALYSIS
5. COMPETITION
slide 2 of 9
6. Ownership
Insider Ownership Masimo Corporation
image
Sold
0-3 MONTHS
1.63 M USD 1
3-6 MONTHS
5.37 M USD 2
6-9 MONTHS
0 USD 0
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
MASI INVESTIGATION ALERT: Johnson Fistel PLLP Investigates the Directors and Officers of Masimo Corporation for Breach of Fiduciary Duties SAN DIEGO--(BUSINESS WIRE)--Johnson Fistel, PLLP, a shareholder rights law firm, announces it is investigating potential breaches of fiduciary duties by certain directors and officers of Masimo Corporation (NASDAQ: MASI) in relation to their obligations to the company's shareholders. What can I do? If you are a current Masimo Corporation shareholder, you may have legal claims that may be brought on behalf of the company, against the company's directors and officers. If you wish to discuss this. businesswire.com - 1 week ago
Masimo to Present in the Jefferies Global Healthcare Conference IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced that its management will participate in the Jefferies Global Healthcare Conference on Wednesday, June 4, 2025 at 1:25 p.m. Eastern time. A live webcast of the presentation will be available on the Masimo website at www.masimo.com. A replay of the webcast will be available following the live presentation. About Masimo Masimo (NASDAQ: MASI) is a global medical technology company that develops and produces a wide array of indus. businesswire.com - 3 weeks ago
MASI INVESTIGATION ALERT: Johnson Fistel PLLP Investigates the Directors and Officers of Masimo Corporation for Breach of Fiduciary Duties SAN DIEGO, May 21, 2025 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP, a shareholder rights law firm, announces it is investigating potential breaches of fiduciary duties by certain directors and officers of Masimo Corporation (NASDAQ: MASI) in relation to their obligations to the company's shareholders. globenewswire.com - 3 weeks ago
Is Masimo (MASI) a Solid Growth Stock? 3 Reasons to Think "Yes" Masimo (MASI) could produce exceptional returns because of its solid growth attributes. zacks.com - 1 month ago
MASI Stock Slips Despite Q1 Earnings and Revenue Beat, Margins Expand Masimo's first-quarter 2025 results continue to benefit from the strength in its Healthcare businesses despite tariff-related uncertainties. zacks.com - 1 month ago
Masimo to Present in the BofA Securities 2025 Health Care Conference IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced that its management will participate in the BofA Securities 2025 Health Care Conference on Tuesday, May 13, 2025 at 4:20 p.m. Pacific time. A live webcast of the presentation will be available on the Masimo website at www.masimo.com. A replay of the webcast will be available following the live presentation. About Masimo Masimo (NASDAQ: MASI) is a global medical technology company that develops and produces a wide array of in. businesswire.com - 1 month ago
Masimo Corporation (MASI) Q1 2025 Earnings Call Transcript Masimo Corporation (NASDAQ:MASI ) Q1 2025 Earnings Conference Call May 7, 2025 4:30 PM ET Company Participants Katie Szyman - Chief Executive Officer Micah Young - Executive Vice President, Chief Financial Officer Eli Kammerman - Vice President of Business Development, Investor Relations Conference Call Participants Frederick Wise - Stifel Financial Vik Chopra - Wells Fargo Jason Bednar - Piper Sandler Mike Matson - Needham Matt Taylor - Jeffries Michael Polark - Wolfe Operator Good afternoon, ladies and gentlemen. And welcome to Masimo's First Quarter 2025 Earnings Conference Call. seekingalpha.com - 1 month ago
Masimo (MASI) Q1 Earnings and Revenues Surpass Estimates Masimo (MASI) came out with quarterly earnings of $1.36 per share, beating the Zacks Consensus Estimate of $1.24 per share. This compares to earnings of $0.77 per share a year ago. zacks.com - 1 month ago
Samsung Electronics says unit Harman acquires Masimo's audio business for $350 mln Samsung Electronics said on Wednesday its unit Harman International signed a deal to acquire U.S. firm Masimo's audio business for $350 million. reuters.com - 1 month ago
Masimo Reports First Quarter 2025 Results IRVINE, Calif.--(BUSINESS WIRE)--Masimo Corporation (Nasdaq: MASI) today announced its financial results for the first quarter ended March 29, 2025. First Quarter 2025 Results From Continuing Operations(1): GAAP revenue of $372 million, representing 10% on a reported basis; Non-GAAP revenue of $371 million, representing 10% on a constant currency basis(3); GAAP net income per diluted of $0.86; and Non-GAAP net income per diluted share(3) of $1.36, which grew 56% versus prior year period. First. businesswire.com - 1 month ago
Masimo to Sell Consumer Audio Business to HARMAN International IRVINE, Calif.--(BUSINESS WIRE)--Masimo Corporation (Nasdaq: MASI), a leading global medical innovator, today announced that it has entered into a definitive agreement to sell its Sound United consumer audio business to HARMAN International (“HARMAN”), a wholly-owned subsidiary of Samsung Electronics Co., Ltd., for an aggregate purchase price of $350 million in cash, subject to certain adjustments. The sale follows the previously announced review of Masimo's consumer audio business and will sup. businesswire.com - 1 month ago
Masimo to Sell Audio Business to Harman After Investor Outrage Samsung's Harman is set to pay around $350 million for the high-end audio-equipment maker. wsj.com - 1 month ago
8. Profile Summary

Masimo Corporation MASI

image
COUNTRY US
INDUSTRY Medical - Instruments & Supplies
MARKET CAP $ 9.2 B
Dividend Yield 0.00%
Description Masimo Corporation develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry. It also provides Masimo rainbow SET platform that includes rainbow SET Pulse CO-Oximetry products that noninvasively monitor hemoglobin species, including oxygen saturation, pulse rate, perfusion index, pleth variability index, and respiration rate from the pleth; noninvasively monitor hemoglobin concentration, and carboxyhemoglobin and methemoglobin; monitor arterial oxygen saturation and acoustic respiration rate; and calculates oxygen content and oxygen reserve index. It offers SedLine brain function monitoring technology to measure the brain's electrical activity by detecting EEG signals; capnography and gas monitoring products comprising external plug-in-and-measure capnography and gas analyzers, integrated modules, handheld capnograph and capnometer devices, and capnography sampling lines; O3 regional oximetry for tissue oxygen saturation measurement; and hemodynamic monitoring solutions. Its Masimo Hospital Automation platform includes Patient SafetyNet, Patient SafetyNet surveillance, Kite, UniView, Replica, UniView : 60, and MyView. It offers connectivity devices; and nasal high flow ventilation and neuromodulation solutions. It provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers; and non-medical/consumer products through e-commerce site, masimopersonalhealth.com. The company was incorporated in 1989 and is headquartered in Irvine, California.
Contact 52 Discovery, Irvine, CA, 92618 https://www.masimo.com
IPO Date Aug. 8, 2007
Employees 3600
Officers Mr. Bilal Muhsin Chief Operating Officer Tetsuro Maniwa President of Masimo Japan Mr. Blair Tripodi Chief Operating Officer of Consumer Division Mr. Eli Kammerman Vice President of Business Development & Investor Relations Ms. Catherine M. Szyman Chief Executive Officer & Director Mr. Micah Young CPA Executive Vice President & Chief Financial Officer Mr. Paul Hataishi Senior Vice President & Chief Accounting Officer Mr. Yongsam Lee Executive Vice President & Chief Information Officer Dr. Steven J. Barker Chairman of Scientific Advisory Board & Chief Science Officer Mr. Anand Sampath Executive Vice President of Operations & Clinical Research